ONCOBAX
LIVE

Serial Number

79214556

Owner

GUSTAVE ROUSSY TRANSFERT

Filing Date

May 29, 2017

Add to watchlist:

No watchlists yet
View on USPTO

ONCOBAX Trademark

Serial Number: 79214556 • Registration: 5483194

ONCOBAX is a trademark filed by GUSTAVE ROUSSY TRANSFERT on May 29, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

GUSTAVE ROUSSY TRANSFERT (3 trademarks)

39 rue Camille Desmoulins

Entity Type: 33

EVERIMMUNE (2 trademarks)

39 rue Camille Desmoulins

Entity Type: 99

Trademark Details

Filing Date

May 29, 2017

Registration Date

June 5, 2018

Published for Opposition

March 20, 2018

Cancellation Date

December 20, 2024

Goods & Services

Computer programs for aiding in the detection, recognition, evaluation, diagnosis and characterization of cancer, for aiding for the treatment and prevention of cancer, for searching for similar cases in databases or archiving systems, and for generating analytical or diagnostic reports; software for aiding in the detection, recognition, evaluation, diagnosis and characterization of cancer, for aiding for the treatment and prevention of cancer, for searching for similar cases in databases or archiving systems, and for generating analytical or diagnostic reports; recorded computer programs regardless of the medium for aiding in the detection, recognition, evaluation, diagnosis and characterization of cancer, for aiding for the treatment and prevention of cancer, for searching for similar cases in databases or archiving systems, and for generating analytical or diagnostic reports; magnetic, electronic, optical, magneto-optical data media, namely, blank magnetic, electronic, optical, magneto-optical data media and prerecorded magnetic, electronic, optical, magneto-optical data media featuring information on cancer, memory cards, CD-ROMs, namely, blank CD-ROM's for recording and prerecorded CD-ROMs featuring information on cancer, digital video disks, namely, blank digital video disks and prerecorded digital video disks featuring information on cancer; optical disks, namely, blank optical disks and pre-recorded optical disks featuring information on cancer; magneto-optical disks, namely, blank magneto-optical disks and prerecorded magneto optical disks, featuring information on cancer; magnetic tapes, namely, blank magnetic tapes and prerecorded magnetic tapes, featuring information on cancer; downloadable software for aiding in the detection, recognition, evaluation, diagnosis and characterization of cancer, for aiding for the treatment and prevention of cancer, for searching for similar cases in databases or archiving systems, and for generating analytical or diagnostic reports; computer programs and software used for the acquisition, visualization, processing, exploitation, annotation, storage, searching, dissemination and printing of all types of medical data, especially of images obtained by a radio-graphic means, by X-ray, scanner, pet scan, ultrasonography, magnetic resonance, tomography for the purpose of cancer screening, diagnosis or treatment, in the medical, surgical and health field and in cancer research; scientific, photographic, cinematographic, optical, measuring apparatus and instruments, namely, computers, microscopes; apparatus for recording transmission and reproduction of sound or images; equipment for processing information, namely, data processing equipment, computers

Surgical apparatus and instruments; medical, dental and veterinary apparatus and instruments, namely, x-ray apparatus, scanner, positron emission tomography (PET) scanners, magnetic resonance imaging scanner, ultrasound scanner, radiotherapy treatment apparatus, artificial limbs, eyes and teeth; orthopedic articles, namely, artificial orthopedic implants, orthopedic bandages and splints, orthopedic braces; suture material

Pharmaceutical products, namely, pharmaceutical preparations for the prevention and treatment of cancer, medicines for the prevention and treatment of cancer and vaccines for treatment and prevention of cancer

Medical services; hospital services; medical analyses, namely, medical analysis and testing for diagnostic or treatment purposes in the area of cancer; medical expertise services, namely, medical diagnostic testing, monitoring, reporting and performing a diagnosis of cancer; health services, namely, treatment of cancer; medical and surgical services, namely, medical diagnostic testing, monitoring, reporting and performing a diagnosis of cancer, surgical treatment of cancer; medical imaging, radiotherapy, brachytherapy and medical dosimetry services for treating cancer; medical diagnosis services, namely, analysis and interpretation of images generated by x-ray apparatus, scanner, positron emission tomography (PET) scanners, magnetic resonance imaging scanner, ultrasound scanner; information services in the field of the fight against cancer, namely, information on cancer treatment

Scientific research services for medical purposes in the area of cancer research, medical research services, research and development of new medical products; research in the fields of bacteriology, biology, chemistry, information services in the field of medical research in the fight against cancer; clinical research in the area of cancer research, medical research and biology medical laboratories; scientific, pharmaceutical, medical and clinical research for new treatments and pharmaceutical products, vaccines, medicines against cancer

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Feb 26, 2026 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 10, 2026 INTS
INVALIDATION PROCESSED
Feb 9, 2026 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 20, 2025 INTR
CANCELLED SECTION 71
Dec 20, 2024 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Apr 13, 2024 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 5, 2023 REM3
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Aug 16, 2022 CORR
CORRECTION TRANSACTION RECEIVED FROM IB
Jul 4, 2022 CRCV
CHANGE OF OWNER RECEIVED FROM IB
May 22, 2022 CHLD
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 6, 2020 TCCA
NEW REPRESENTATIVE AT IB RECEIVED
Jan 23, 2020 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 6, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 17, 2018 FICS
FINAL DISPOSITION PROCESSED
Sep 17, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 5, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 5, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 20, 2018 NPUB
PUBLISHED FOR OPPOSITION
Mar 20, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 28, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 14, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 14, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 14, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 14, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 14, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 25, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2018 CRFA
ASSIGNED TO LIE
Jan 25, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 11, 2018 TROA
REFUSAL PROCESSED BY IB
Sep 22, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 2, 2017 RFCS
REFUSAL PROCESSED BY MPU
Sep 2, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 31, 2017 RFCR
NON-FINAL ACTION WRITTEN
Aug 30, 2017 CNRT
ASSIGNED TO EXAMINER
Aug 28, 2017 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 25, 2017 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 21, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 17, 2017 REPR